Latest News
Webinar: Using Transcranial Magnetic Stimulation to Probe Inhibitory Activity in Patients and Healthy Controls
From Setback to Strategy: Rethinking Cognitive Schizophrenia Trials -Why the CONNEX trials Failed
Design-driven foresight in CNS Drug Development: Bridging the valley of death
Advances in CNS trials: Key 2025 milestones and 2026 outlook
Harnessing Neurophysiological Biomarkers to Accelerate Therapeutic Development in Rett Syndrome
Webinar - Probing Sodium Channel Blockers In Vivo: TMS Strength–Duration Metrics as a Translational Biomarker
Pain and Quantitative Sensory Testing in Clinical Trials: Why it Matters for CNS Drug Development
Alzheimer's Disease in Clinical Trials
How TMS is Reshaping Clinical Research
2024 Breakthroughs and 2025 Innovations in Neuroscience Phase I Clinical Trials
Utility of TMS and EEG in Phase 1 Drug Trials for Alzheimer’s Disease
MHRA Timelines Back on Track